Risk-Adapted Management of Thyroid Cancer

Hundahl, 2000, (U.S. and German Thyroid Cancer Study Group). Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996: an American College of Surgeons Commission on Cancer patient care evaluation study, Cancer, 89, 202, 10.1002/1097-0142(20000701)89:1<202::AID-CNCR27>3.0.CO;2-A Tuttle, 2008, Follow up approaches in thyroid cancer: a risk adapted paradigm, Endocrinol Metab Clin North Am, 37, 419, 10.1016/j.ecl.2008.02.008 Tuttle, 2008, Medical management of thyroid cancer: a risk adapted approach, J Surg Oncol, 97, 712, 10.1002/jso.21010 Mazzaferri, 2007, Management of low-risk differentiated thyroid cancer, Endocr Pract, 13, 498, 10.4158/EP.13.5.498 Mazzaferri, 2001, Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer, J Clin Endocrinol Metab, 86, 1447, 10.1210/jcem.86.4.7407 Cooper, 2006, (American Thyroid Association Guidelines Taskforce). Management guidelines for patients with thyroid nodules and differentiated thyroid cancer, Thyroid, 16, 109, 10.1089/thy.2006.16.109 Pacini, 2006, European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium, Eur J Endocrinol, 154, 787, 10.1530/eje.1.02158 Shaha, 1997, Low-risk differentiated thyroid cancer: the need for selective treatment, Ann Surg Oncol, 4, 328, 10.1007/BF02303583 2006, American Cancer Society, Inc. Cancer Facts and Figures Byar, 1979, A prognostic index for thyroid carcinoma: a study of the E.O.R.T.C. Thyroid Cancer Cooperative Group, Eur J Cancer, 15, 1033, 10.1016/0014-2964(79)90291-3 Cady, 1988, An expanded view of risk-group definition in differentiated thyroid carcinoma, Surgery, 104, 947 Dean, 2000, Prognostic indicators in differentiated thyroid carcinoma, Cancer Control, 7, 229, 10.1177/107327480000700302 Hay, 1993, Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989 [with discussion], Surgery, 114, 1050 Hay, 1987, Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system, Surgery, 102, 1088 Mazzaferri, 1994, Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer [published correction appears in Am J Med. 1995;98:215], Am J Med, 97, 418, 10.1016/0002-9343(94)90321-2 Shaha, 1995, Prognostic factors and risk group analysis in follicular carcinoma of the thyroid [with discussion], Surgery, 118, 1131, 10.1016/S0039-6060(05)80124-2 2007, National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Thyroid Carcinoma. V.2 Sherman, 1998, (National Thyroid Cancer Treatment Cooperative Study Registry Group). Prospective multicenter study of thyroid carcinoma treatment: initial analysis of staging and outcome, Cancer, 83, 1012, 10.1002/(SICI)1097-0142(19980901)83:5<1012::AID-CNCR28>3.0.CO;2-9 Lang, 2007, Staging systems for papillary thyroid carcinoma: a review and comparison, Ann Surg, 245, 366, 10.1097/01.sla.0000250445.92336.2a Ito, 2007, Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection, World J Surg, 31, 2085, 10.1007/s00268-007-9224-y Welsch, 2007, Multiparameter scoring system for the prognosis of differentiated thyroid cancer [with quiz], Nuklearmedizin, 46, 257 Kim, 2005, Serum thyroglobulin levels at the time of 131I remnant ablation just after thyroidectomy are useful for early prediction of clinical recurrence in low-risk patients with differentiated thyroid carcinoma, J Clin Endocrinol Metab, 90, 1440, 10.1210/jc.2004-1771 Lin, 2002, Significance of postoperative serum thyroglobulin levels in patients with papillary and follicular thyroid carcinomas, J Surg Oncol, 80, 45, 10.1002/jso.10089 Tuttle, 2008, Recombinant human TSH-assisted radioactive iodine remnant ablation achieves short-term clinical recurrence rates similar to those of traditional thyroid hormone withdrawal, J Nucl Med, 49, 764, 10.2967/jnumed.107.049072 Baudin, 1998, Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experience, Cancer, 83, 553, 10.1002/(SICI)1097-0142(19980801)83:3<553::AID-CNCR25>3.0.CO;2-U Chow, 2003, Papillary microcarcinoma of the thyroid—prognostic significance of lymph node metastasis and multifocality, Cancer, 98, 31, 10.1002/cncr.11442 Wang, 2001, Resistance of [18F]-fluorodeoxyglucose-avid metastatic thyroid cancer lesions to treatment with high-dose radioactive iodine, Thyroid, 11, 1169, 10.1089/10507250152741028